-
11.
公开(公告)号:US20090326003A1
公开(公告)日:2009-12-31
申请号:US12374331
申请日:2007-07-19
IPC分类号: A61K31/437 , C07D471/04 , A61P11/06 , A61P17/06
CPC分类号: C07D519/00
摘要: The present invention provides a compound of formula (I) or a salt thereof (in particular, a pharmaceutically acceptable salt thereof): The invention also provides the use of the compounds or salts as inhibitors of phosphodiesterase type IV (PDE4) for the treatment or prophylaxis of inflammatory or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rhinitis, atopic dermatitis or psoriasis, e.g. in a mammal such as a human.
摘要翻译: 本发明提供式(I)化合物或其盐(特别是其药学上可接受的盐):本发明还提供了化合物或盐作为IV型磷酸二酯酶抑制剂(PDE4)用于治疗或 预防炎症或过敏性疾病如慢性阻塞性肺疾病(COPD),哮喘,鼻炎,特应性皮炎或牛皮癣,例如 在哺乳动物如人中。